Continuous Glucose Monitor Use for Mayo Clinic Advanced Care at Home Patients With Diabetes Mellitus
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this study is to measure differences in diabetes control with the use of continuous glucose monitor (CGM) and diabetes education compared with standard of care for glucose monitoring (glucometer checks) and diabetes education in participants with diabetes mellitus receiving therapy with insulin and being admitted to Mayo Clinic Advanced Care at Home Program (ACH).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients who are admitted to Advanced Care at Home (ACH) Program and supposed to remain in ACH for at least 72 hours.
• Patients with previous diagnosis of DM type 1 or type 2.
• Patients taking subcutaneous (SQ) insulin either via multidose injections or SQ insulin pump.
• Capable of giving signed informed consent
Locations
United States
Florida
Mayo Clinic in Florida
RECRUITING
Jacksonville
Time Frame
Start Date: 2024-05-01
Estimated Completion Date: 2027-05
Participants
Target number of participants: 100
Treatments
Experimental: Continuous Glucose Monitoring
Subjects admitted to the Advanced Care at Home program (home hospital) will have the continuous glucose monitor sensor placed for up to 10 days to monitor and dose insulin.
No_intervention: Control Arm (Standard of Care)
Subjects admitted to the Advanced Care at Home program (home hospital) will continue with standard of care glucose monitoring (capillary glucose levels checked via glucometer), insulin dosing, and DM treatment during the 10 day period.
Related Therapeutic Areas
Sponsors
Leads: Mayo Clinic